184 related articles for article (PubMed ID: 24986663)
1. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells.
Bourguet CB; Boulay PL; Claing A; Lubell WD
Bioorg Med Chem Lett; 2014 Aug; 24(15):3361-5. PubMed ID: 24986663
[TBL] [Abstract][Full Text] [Related]
2. Application of constrained aza-valine analogs for Smac mimicry.
Chingle R; Ratni S; Claing A; Lubell WD
Biopolymers; 2016 May; 106(3):235-44. PubMed ID: 27087660
[TBL] [Abstract][Full Text] [Related]
3. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
4. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
Chingle R; Proulx C; Lubell WD
Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
[TBL] [Abstract][Full Text] [Related]
5. Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain.
Kurian LA; Silva TA; Sabatino D
Bioorg Med Chem Lett; 2014 Sep; 24(17):4176-80. PubMed ID: 25127870
[TBL] [Abstract][Full Text] [Related]
6. Regioselective synthesis of polycyclic aza-oxa and aza-oxa-thia heteroarenes as Colo-205 and HepG2 carcinoma cells growth inhibitors.
Maurya HK; Gautam SK; Pratap R; Tandon VK; Kumar A; Kumar B; Saxena S; Tripathi D; Rajwanshi M; Das M; Ram VJ
Eur J Med Chem; 2014 Jun; 81():367-77. PubMed ID: 24858542
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway.
Yang L; Cui Y; Shen J; Lin F; Wang X; Long M; Wei J; Zhang H
Drug Des Devel Ther; 2015; 9():1319-30. PubMed ID: 25767377
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis.
Sabatino D; Proulx C; Pohankova P; Ong H; Lubell WD
J Am Chem Soc; 2011 Aug; 133(32):12493-506. PubMed ID: 21692501
[TBL] [Abstract][Full Text] [Related]
9. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
[TBL] [Abstract][Full Text] [Related]
13. A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells.
Onen-Bayram FE; Durmaz I; Scherman D; Herscovici J; Cetin-Atalay R
Bioorg Med Chem; 2012 Sep; 20(17):5094-102. PubMed ID: 22867707
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines.
Patitungkho S; Adsule S; Dandawate P; Padhye S; Ahmad A; Sarkar FH
Bioorg Med Chem Lett; 2011 Mar; 21(6):1802-6. PubMed ID: 21316236
[TBL] [Abstract][Full Text] [Related]
16. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel peptides through Ugi-ligation and their anti-cancer activities.
Tahoori F; Sheikhnejad R; Balalaie S; Sadjadi M
Amino Acids; 2013 Oct; 45(4):975-81. PubMed ID: 23864432
[TBL] [Abstract][Full Text] [Related]
18. Aromatic oligopeptides with chlorambucil moiety--synthesis and biological evaluation.
Bartulewicz D
Acta Pol Pharm; 2005; 62(6):451-5. PubMed ID: 16583984
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic simplified tubulysin analogues.
Raghavan B; Balasubramanian R; Steele JC; Sackett DL; Fecik RA
J Med Chem; 2008 Mar; 51(6):1530-3. PubMed ID: 18314944
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
